Orally administered pharmaceutical composition for the treatment of irritable bowel syndrome, which comprises a modifier of intestinal motility, an agent that prevents the retention of digestive enzymes and gases, and its preparation procedure

摘要

A pharmaceutical composition or formulation adapted for oral administration in the form of a tablet, coated tablet or capsule in the prevention or treatment of intestinal disorders such as irritable bowel syndrome, also known as irritable bowel syndrome, based on a motility modifier intestinal, an agent that prevents the retention of gases, digestive enzymes of a binding agent, a diluting agent, an adsorbent agent, a disintegrating agent, a lubricating agent and a sliding agent, effective to normalize the intestinal transit, to achieve an analgesic activity, to achieve an antispasmodic activity and to reduce the symptoms related to intestinal gas such as bloating, abdominal pain and flatulence.